Cargando…

Other Community Respiratory Viruses

Polymerase chain reaction–based diagnosis has become the standard for viral pneumonia and other respiratory tract infections. Expansion of respiratory viral panels (RVPs) outside of influenza and, possibly, respiratory syncytial virus has led to the ability to diagnose viral infections for which no...

Descripción completa

Detalles Bibliográficos
Autor principal: Wunderink, Richard G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131595/
https://www.ncbi.nlm.nih.gov/pubmed/28159160
http://dx.doi.org/10.1016/j.ccm.2016.11.003
_version_ 1783517274591723520
author Wunderink, Richard G.
author_facet Wunderink, Richard G.
author_sort Wunderink, Richard G.
collection PubMed
description Polymerase chain reaction–based diagnosis has become the standard for viral pneumonia and other respiratory tract infections. Expansion of respiratory viral panels (RVPs) outside of influenza and, possibly, respiratory syncytial virus has led to the ability to diagnose viral infections for which no approved specific antiviral treatment exists. Careful clinical evaluation of the patient with a positive RVP is, therefore, critical given the limited repertoire of treatments. Generic treatments with intravenous immunoglobulin, ribavirin, and interferons may benefit select severe viral pneumonia patients, whereas cidofovir has activity for severe adenoviral pneumonia.
format Online
Article
Text
id pubmed-7131595
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-71315952020-04-08 Other Community Respiratory Viruses Wunderink, Richard G. Clin Chest Med Article Polymerase chain reaction–based diagnosis has become the standard for viral pneumonia and other respiratory tract infections. Expansion of respiratory viral panels (RVPs) outside of influenza and, possibly, respiratory syncytial virus has led to the ability to diagnose viral infections for which no approved specific antiviral treatment exists. Careful clinical evaluation of the patient with a positive RVP is, therefore, critical given the limited repertoire of treatments. Generic treatments with intravenous immunoglobulin, ribavirin, and interferons may benefit select severe viral pneumonia patients, whereas cidofovir has activity for severe adenoviral pneumonia. Elsevier Inc. 2017-03 2016-12-04 /pmc/articles/PMC7131595/ /pubmed/28159160 http://dx.doi.org/10.1016/j.ccm.2016.11.003 Text en © 2016 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Wunderink, Richard G.
Other Community Respiratory Viruses
title Other Community Respiratory Viruses
title_full Other Community Respiratory Viruses
title_fullStr Other Community Respiratory Viruses
title_full_unstemmed Other Community Respiratory Viruses
title_short Other Community Respiratory Viruses
title_sort other community respiratory viruses
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131595/
https://www.ncbi.nlm.nih.gov/pubmed/28159160
http://dx.doi.org/10.1016/j.ccm.2016.11.003
work_keys_str_mv AT wunderinkrichardg othercommunityrespiratoryviruses